Literature DB >> 5768131

The interactions of noradnamine and imipramine-like antidepressant drugs.

P Cowell.   

Abstract

1. The hypothesis of Roberts & Broadley (1965) that noradnamine formation in the brain is responsible for endogenous depression has been investigated in mice.2. Injections of noradnamine given directly into the lateral ventricles caused convulsions and profound hypothermia, but were without effect if given subcutaneously.3. The hypothermia, but not the convulsions, induced by noradnamine was reversed by imipramine-like antidepressant drugs given before or after the injection of noradnamine. The convulsions but not the hypothermia were abolished by phenobarbitone.4. Increasing doses of nortriptyline produced a parallel shift of the hypothermic log dose-response curve for intraventricular injections of noradnamine to the right.5 The minimal effective dose of nortriptyline required to reverse noradnamine hypothermia was the same whether the nortriptyline was injected directly into the lateral ventricle or subcutaneously.6. No evidence was found to substantiate the claim that reserpine hypothermia is mediated by noradnamine formation in the brain.7. Intraventricular, but not intraperitoneal, injection of noradnamine caused a depletion of brain noradrenaline and an increase in brain 5-hydroxytryptamine. These changes did not result from the convulsive activity and were not modified by pretreatment with nortriptyline. No effect on heart noradrenaline levels was recorded.8. Noradrenaline, given subcutaneously, also antagonized the hypothermic response to noradnamine.9. The reversal of noradnamine hypothermia by both noradrenaline given subcutaneously and nortriptyline was blocked by alpha and beta-adrenoceptive receptor blocking agents.10. It is considered that the mode of action of the antagonism of noradnamine hypothermia by imipramine-like antidepressant drugs is a peripheral and not a central mechanism and probably results from a potentiation of the effects of circulating noradrenaline released by noradnamine.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5768131      PMCID: PMC1703538          DOI: 10.1111/j.1476-5381.1969.tb08306.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  8 in total

1.  MEASUREMENT OF BODY TEMPERATURE IN CONSCIOUS SMALL LABORATORY ANIMALS BY MEANS OF AN OESOPHAGEAL THERMOCOUPLE.

Authors:  R T BRITTAIN; P S SPENCER
Journal:  J Pharm Pharmacol       Date:  1964-07       Impact factor: 3.765

2.  A SEMIAUTOMATIC METHOD FOR DETERMINATION OF CATECHOLAMINES.

Authors:  R J MERRILLS
Journal:  Anal Biochem       Date:  1963-09       Impact factor: 3.365

3.  A SIMPLE SCREENING PROCEDURE FOR IMIPRAMINE-LIKE ANTIDEPRESSANT AGENTS.

Authors:  B M ASKEW
Journal:  Life Sci (1962)       Date:  1963-10

4.  TREATMENT OF DEPRESSION.

Authors:  D J ROBERTS; K J BROADLEY
Journal:  Lancet       Date:  1965-06-05       Impact factor: 79.321

5.  Microanalytical procedures for fluorometric assay of brain DOPA-5HTP decarboxylase, norepinephrine and serotonin, and a detailed mapping of decarboxylase activity in brain.

Authors:  R KUNTZMAN; P A SHORE; D BOGDANSKI; B B BRODIE
Journal:  J Neurochem       Date:  1961-02       Impact factor: 5.372

6.  Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse.

Authors:  T J HALEY; W G MCCORMICK
Journal:  Br J Pharmacol Chemother       Date:  1957-03

7.  Some observations on the central pharmacological actions of noradnamine, a proposed depressive catabolite of noradrenaline.

Authors:  D M Chambers; P H Redfern; D J Roberts
Journal:  Int J Neuropharmacol       Date:  1967-09

8.  The reversal of the central effects of noradrenaline by antidepressant drugs in mice.

Authors:  P Cowell; M J Davey
Journal:  Br J Pharmacol       Date:  1968-09       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.